Public consultation on current regulatory testing requirements for medicines and opportunities for the implementation of NAMs

EMA is reinforcing its commitment to ethical and humane research through the 3Rs principles:
:arrows_counterclockwise: Replacement – Finding alternatives to animal testing
:chart_with_downwards_trend: Reduction – Minimizing animal use
:blue_heart: Refinement – Reducing animal suffering

They want your insights! :bulb: EMA has launched a public consultation to gather feedback on current regulatory testing requirements for medicines, as well as on opportunities for the implementation of 3Rs principles for medicine development. The revised EMA reflection paper provide the state-of-the-art 3Rs tools that can already be used and opportunities for the future. This is your chance to:

:white_check_mark: Share experiences of the current testing requirements
:white_check_mark: Suggest new opportunities for innovative 3Rs method implementation
:white_check_mark: Highlight challenges and barriers in applying these opportunities.

:spiral_calendar: Deadline: 30 June 2025
Read more in the recently published reflection paper on human medicines: Draft Reflection paper on the current regulatory testing requirements for medicinal products for human use and opportunities for implementation of the 3Rs.

:exclamation:The FDA also has the ambition to phase out animal testing. Want to know more? Check out: FDA Roadmap to Reducing Animal Testing in Preclinical Safety Studies